Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes

Colloids and Surfaces B: Biointerfaces

Volumn 87, Issue 1, 2011, Pages 173-179

  Mehta, Surinder K ^a   Jindal, Neha ^a   Kaur, Gurpreet ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Anti tuberculosis drugs; Encapsulation; Niosomes; Release; Stability

Indexed keywords

ANTI-TUBERCULOSIS DRUGS; DISTRIBUTION COEFFICIENT; ENCAPSULATION EFFICIENCY; FLUORESCENCE PROBES; IN-VITRO; MEAN SIZE; MULTIDRUG RESISTANCE; NIOSOMES; NON-FICKIAN; PARTICLE SIZE ANALYZERS; PYRAZINAMIDE; QUANTITATIVE INVESTIGATION; RELEASE; RELEASE BEHAVIORS; RELEASE MECHANISM; SPAN 80; TRITON X-100;

EFFICIENCY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; GLYCOLS; PARTICLE SIZE ANALYSIS; POLYETHYLENE GLYCOLS; SCANNING ELECTRON MICROSCOPY;

ENCAPSULATION;

ISONIAZID; MACROGOL; NIOSOME; OCTOXINOL; PYRAZINAMIDE; RIFAMPICIN; SORBITAN OLEATE; TRITON X 100; TUBERCULOSTATIC AGENT;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; ENCAPSULATION; EXCIPIENT COMPATIBILITY; FLUORESCENCE SPECTROSCOPY; IN VITRO STUDY; MOLECULAR WEIGHT; MULTIDRUG RESISTANT TUBERCULOSIS; PARTICLE SIZE; PHOTOCHEMICAL QUENCHING; PRIORITY JOURNAL; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

ANTITUBERCULAR AGENTS; DRUG STABILITY; FLUORESCENCE; KINETICS; LIPOSOMES; MODELS, CHEMICAL; OCTOXYNOL; PARTICLE SIZE; REFERENCE STANDARDS; SOLUBILITY; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; THERMODYNAMICS;

EID: 79959332926     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.05.018     Document Type: Article

References (46)

1. Ristsehel W.A. Methods Find. Exp. Clin. Pharmacol. 1991, 13:205.
2. Kaur I.P., Garg A., Singla A.K., Aggarwal D. Int. J. Pharm. 2004, 269:1.
3. Damge C., Vranckx H., Balschmidt P., Couvreur P. J. Pharm. Sci. 1997, 86:1403.
4. Sareiaux J.M., Acar L., Sado P.A. Int. J. Pharm. 1995, 120:127.
5. Morishita M., Morishita I., Takayama K., Machida Y., Nagai T. Int. J. Pharm. 1992, 78:1.
6. Kato T., Nemoto R., Mori H., Abe R., Unno K., Goto A., Murota H., Harada M., Homma M. Appl. Biochem. Biotechnol. 1984, 10:199.
7. Liu T., Guo R., Hua W., Qiu J. Colloids Surf. A 2007, 293:255.
8. Sato Y., Kiwada H., Kato Y. Chem. Pharm. Bull. (Tokyo) 1986, 34:4244.
9. Handjani-Vila R.M., Rlbier A., Rondot B., Vanlerberghe G. Int. J. Cosmetic Sci. 1979, 1:303.
10. Fang J.-Y., Yu S.-Y., Wu P.-C., Huang Y.-B., Tsai Y.-H. Int. J. Pharm. 2001, 215:91.
11. Tsuchihashi M., Harashima H., Kiwada H. J. Controlled Release 1999, 61:9.
12. Bandak S., Ramu A., Barenholz Y., Gabuzon A. Pharm. Res. 1999, 16:841.
13. Gabizon A., Goren D., Cohen R., Barenholz Y. J. Controlled Release 1998, 53:275.
14. Berry G., Billingham M., Alderman E., Richardson P., Torti F., Lum B., Patek A., Martin F.J. Ann. Oncol. 1998, 9:711.
15. Boswell G.W., Buell D., Bekersky I. J. Clin. Pharmacol. 1998, 38:583.
16. Florence A.T., Baillie A.J. Novel Drug Delivery and its Therapeutic Applications 1989, 281. John Wiley and Sons Ltd. L.F. Prescott, W.S. Nimmo (Eds.).
17. Manosroi A., Manosroi J. J. Microencapsulation 1997, 14:761.
18. Manosroi A., Bauer K.H. Drug Dev. Ind. Pharm. 1990, 16:807.
19. Baillie J., Florence A.T. J. Pharm. Pharmacol. 1985, 37:863.
20. Uchegbu I.F., Florence A.T. Adv. Colloid Interface Sci. 1995, 58:1.
21. Uchegbu I.F., Vyas S.P. Int. J. Pharm. 1998, 172:33.
22. Mao M., Huang J., Zhu B., Ye J. J. Phys. Chem. B 2002, 106:219.
23. Azmin M.N., Florence A.T., Handjani-Vila R.M., Stuart J.F.B., Vanlerberghe G., Whittaker J.S. J. Pharm. Pharmacol. 1985, 37:237.
24. Azmin M.N., Florence A.T., Handjani-Vila R.M., Stuart J.F.B., Vanlerberghe G., Whittaker J.S. J. Microencapsulation 1986, 3:95.
25. Baillie A.J., Coombs G.H., Dolan T.F., Laurie J. J. Pharm. Pharmacol. 1986, 38:502.
26. Hunter C.A., Dolan T.F., Coombs G.H., Baillie A.J. J. Pharm. Pharmacol. 1988, 40:161.
27. Rogerson A., Cummings J., Willmott N., Florence A.T. J. Pharm. Pharmacol. 1988, 40:337.
28. Kerr D.J., Rogerson A., Morrison G.J., Florence A.T., Kaye S.B. Br. J. Cancer 1988, 58:432.
29. Erdogan S., Ö zer A.Y., Ercan M.T., Eryilmaz M., Hincal A.A. STP Pharma. Sci. 1996, 6:87.
30. Kasim N.A., Whitehouse M., Ramachandran C., Bermejo M., Lennernas H., Hussian A.S., Junginger H.E., Stavchansky S.A., Midha K.K., Shah V.P., Amidon G.L. Mol. Pharmaceutics 2004, 1:85.
31. Panchganula R., Agrawal S. Int. J. Pharm. 2004, 271:1.
32. Du Toit L.C., Pillay V., Danckwerts M.P. Respir. Res. 2006, 7:118.
33. Hao Y., Zhao F., Li N., Yang Y., Li K. Int. J. Pharm. 2002, 244:73.
34. Vostrikov V.V., Selishcheva A.A., Sorokoumova G.M., Shakina Y.N., Shvets V.I., Oleg Yu., Savel'ev V.I., Polshakov Eur. J. Pharm. Biopharm. 2008, 68:400.
35. Kalynasundaram K., Thomas J.K. J. Am. Chem. Soc. 1977, 99:2039.
36. Liu T., Guo R. Langmuir 2005, 21:11034.
37. Zhang J.A., Anyarambhatla G., Ma L., Ugwu S., Xuan T., Sardone T., Ahmad I. Eur. J. Pharm. Biopharm. 2005, 59:177.
38. Zhang L., Sun X., Zhang Z.R. Drug Deliv. 2005, 12:289.
39. Dai H., Chen Q., Qin H., Guan Y., Shen D., Hua Y., Tang Y., Xu J. Macromolecules 2006, 39:6584.
40. Washington C. Int. J. Pharm. 1990, 58:1.
41. Moghimi S.M., Szebeni J. Prog. Lipid Res. 2003, 42:463.
42. Tamizharasi S., Dubey A., Rathi V., Rathi J.C. J. Young Pharm. 2009, 1:205.
43. Varshosaz J., Pardakhty A., Hajhashemi V-i. Drug Deliv. 2003, 10:25.
44. Jia L., Garza M., Wong H., Reimer D., Redelmeier T., Camden J.B., Weitman S.D. J. Pharm. Biomed. Anal. 2002, 28:65.
45. Rangasamy M., Ayyasamy B., Raju S., Gummadevelly S., Shaik S. J. Pharm. Res. 2008, 1:163.
46. Ellenhorn M.J., Barceloux D.G. Medical Toxicology: Diagnosis and Treatment of Human Poisoning 1988, Vol. 29. Amsterdam, Elsevier.